Leap Therapeutics Inc (LPTX)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Leap Therapeutics Inc (LPTX) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8010992
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Leap Therapeutics Inc (Leap Therapeutics) is a clinical-stage biopharmaceutical company that acquires, develops novel therapeutics for cancer research. The company’s pipeline encompasses DKN-01, a humanized monoclonal antibody that targets the Dickkopf-1 (DKK-1) protein, and in clinical trials for the treatment of in esophageal cancer, cholangiocarcinoma, a form of bile duct cancer; and non-small cell lung cancer. Its TRX518, is a humanized anti-GITR (glucocorticoid-induced tumor necrosis factor receptor) monoclonal antibody that enhances the immune system’s anti-tumor response and is in Phase 1 clinical trials for the treatment of solid tumors. Leap Therapeutics is headquartered in Cambridge, Massachusetts, the US.

Leap Therapeutics Inc (LPTX) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Leap Therapeutics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Leap Therapeutics Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Leap Therapeutics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Leap Therapeutics Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Leap Therapeutics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Leap Therapeutics Inc, Medical Equipment, Deal Details 10
Merger 10
GITR Merges with HealthCare Pharmaceuticals to Form Leap Therapeutics 10
Equity Offering 11
Leap Therapeutics Plans to Raise Funds in Secondary Offering of Shares 11
Leap Therapeutics to Raise USD18 Million in Private Placement of Units 12
Acquisition 14
Leap Therapeutics Acquires Macrocure 14
Leap Therapeutics Inc – Key Competitors 16
Leap Therapeutics Inc – Key Employees 17
Leap Therapeutics Inc – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Leap Therapeutics Inc, Medical Equipment, Key Facts, 2015 2
Leap Therapeutics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Leap Therapeutics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Leap Therapeutics Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Leap Therapeutics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Leap Therapeutics Inc, Deals By Market, 2011 to YTD 2017 8
Leap Therapeutics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
GITR Merges with HealthCare Pharmaceuticals to Form Leap Therapeutics 10
Leap Therapeutics Plans to Raise Funds in Secondary Offering of Shares 11
Leap Therapeutics to Raise USD18 Million in Private Placement of Units 12
Leap Therapeutics Acquires Macrocure 14
Leap Therapeutics Inc, Key Competitors 16
Leap Therapeutics Inc, Key Employees 17
Leap Therapeutics Inc, Subsidiaries 18

★海外企業調査レポート[Leap Therapeutics Inc (LPTX)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Murray & Roberts Holdings Ltd (MUR):企業の財務・戦略的SWOT分析
    Murray & Roberts Holdings Ltd (MUR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Soitec SA (SOI)-エネルギー分野:企業M&A・提携分析
    Summary Soitec S.A. (Soitec) is a designer and manufacturer of semiconductor materials. The company offers solutions for miniaturizing chips. Its products are used to manufacture chips which are used in smartphones, tablets, computers, IT servers and data centers, electronic components in cars, conn …
  • ImevaX GmbH-製薬・医療分野:企業M&A・提携分析
    Summary ImevaX GmbH (ImevaX) is a biopharmaceutical company that develops specific vaccines against chronic infections. The company identifies and uses immune modulatory bacterial factors to develop specific vaccines. It develops specific vaccines against pathogens that cause chronic infectious dise …
  • National Oilwell Varco Inc (NOV)-石油・ガス分野:企業M&A・提携分析
    Summary National Oilwell Varco, Inc. (NOV) designs, manufactures and services a broad range of drilling and well servicing equipment and components for the oil and gas sector. Its offerings include rig systems, wellbore technologies, and completion and production technologies. Its product line compr …
  • Canadian Utilities Limited:企業の戦略・SWOT・財務分析
    Canadian Utilities Limited - Strategy, SWOT and Corporate Finance Report Summary Canadian Utilities Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • GarrettCom, Inc.:企業の戦略的SWOT分析
    GarrettCom, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Grant Thornton International Ltd:企業の戦略的SWOT分析
    Grant Thornton International Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Biocartis Group NV (BCART) – Product Pipeline Analysis, 2018 Uate
    Summary Biocartis Group NV (Biocartis) is a molecular diagnostics company that provides personalized medicine for patients through its molecular diagnostics. The company undertakes the development of diagnostics technology platforms for multiplexed detection of bio-analytes, with oncology as its key …
  • BioView Ltd (BIOV)-医療機器分野:企業M&A・提携分析
    Summary BioView Ltd (BioView) is a medical device company that develops, manufactures and markets automated cell imaging and analysis solutions, which incorporate proprietary imaging, analysis and review technology. The technology provides automatic control of fully motorized fluorescent and bright- …
  • Masimo Corp (MASI):企業の財務・戦略的SWOT分析
    Masimo Corp (MASI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • TenneT Holding BV-エネルギー分野:企業M&A・提携分析
    Summary TenneT Holding BV (TenneT), owned by the Ministry of Finance of The State of the Netherlands, is an electricity transmission system operator. The company offers electricity transmission and system services. It constructs and maintains high voltage grid to transmit electricity from the produc …
  • PTC, Inc. (PTC):企業の財務・戦略的SWOT分析
    PTC, Inc. (PTC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Arabtec Holding:企業の戦略・SWOT・財務情報
    Arabtec Holding - Strategy, SWOT and Corporate Finance Report Summary Arabtec Holding - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Azelis Holding S.A.:企業の戦略・SWOT・財務情報
    Azelis Holding S.A. - Strategy, SWOT and Corporate Finance Report Summary Azelis Holding S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • University of Copenhagen:製薬・医療:M&Aディール及び事業提携情報
    Summary University of Copenhagen (UCPH) is a university and research institution that offers educational and research programs and services. The university’ services include graduate and undergraduate courses, research programs, master's programs, continuing education services, online courses, inter …
  • SoftTech Yazılım Teknolojileri Arastırma Gelistirme ve Pazarlama Ticaret A.S.:企業の戦略・SWOT・財務情報
    SoftTech Yazılım Teknolojileri Arastırma Gelistirme ve Pazarlama Ticaret A.S. - Strategy, SWOT and Corporate Finance Report Summary SoftTech Yazılım Teknolojileri Arastırma Gelistirme ve Pazarlama Ticaret A.S. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data a …
  • Align Technology, Inc.:戦略・SWOT・企業財務分析
    Align Technology, Inc. - Strategy, SWOT and Corporate Finance Report Summary Align Technology, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Ciber Global, LLC:企業の戦略・SWOT・財務分析
    Ciber Global, LLC - Strategy, SWOT and Corporate Finance Report Summary Ciber Global, LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Alnylam Pharmaceuticals Inc (ALNY)-医療機器分野:企業M&A・提携分析
    Summary Alnylam Pharmaceuticals Inc, (Alnylam) is a biopharmaceutical company which discovers, develops and commercializes therapeutics based on Ribo Nucleic Acid interference (RNAi). The company offers a broad pipeline of investigational RNAi therapeutics in the areas of genetic medicines; cardiova …
  • Turkiye Halk Bankasi AS:企業の戦略・SWOT・財務分析
    Turkiye Halk Bankasi AS - Strategy, SWOT and Corporate Finance Report Summary Turkiye Halk Bankasi AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆